文献速递传染病防控与疫情报告

基于Salp14表位的mRNA疫苗可诱导对蜱叮咬的早期识别

Salp14 epitope-based mRNA vaccination induces early recognition of a tick bite.
PubMed 文献 · Vaccine · 2024-09-05

研究用编码肩突硬蜱唾液蛋白Salp14羧基端25个氨基酸的脂质纳米颗粒mRNA(Salp14-C mRNA-LNP)免疫豚鼠,动物产生针对Salp14羧基端的高滴度IgG;再暴露于肩突硬蜱后,叮咬部位出现红斑。叮咬部位皮肤转录组学显示组胺激活等通路与红斑形成相关,表明编码小肽的mRNA疫苗可在豚鼠中诱导获得性蜱抵抗的初期阶段。

要点

  • Salp14-C mRNA-LNP免疫豚鼠产生针对Salp14羧基端的高滴度IgG。
  • 免疫后暴露于肩突硬蜱,豚鼠叮咬部位出现红斑。
  • 叮咬部位皮肤转录组学显示组胺激活等通路与红斑相关。

核心结论

  • 编码Salp14羧基端小肽的mRNA疫苗可在豚鼠中诱导获得性蜱抵抗的初始阶段。

研究设计与样本

  • 研究用含编码Salp14羧基端25个氨基酸mRNA的脂质纳米颗粒(Salp14-C mRNA-LNP)免疫豚鼠,随后暴露于肩突硬蜱并观察叮咬部位反应。

主要发现

  • 免疫豚鼠产生针对Salp14羧基端的高滴度IgG。
  • 免疫豚鼠暴露于肩突硬蜱后叮咬部位出现红斑。
  • 叮咬部位皮肤转录组学显示组胺激活等通路与红斑形成相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Repeated exposure of animals to Ixodes scapularis ticks can result in acquired tick resistance (ATR). The first manifestation of ATR is erythema at the tick bite site, however, the specific peptide targets and mechanisms associated with this early aspect of ATR are not understood. In this study, we immunized guinea pigs with a lipid nanoparticle containing the mRNA encoding 25 amino acids in the carboxyl terminus of Salp14 (Salp14-C mRNA-LNP), an I. scapularis salivary protein. The animals produced high titers of IgG directed at the carboxyl terminus of Salp14. Guinea pigs immunized with Salp14-C mRNA-LNP and then exposed to I. scapularis, developed erythema at the tick bite site. Transcriptomics of the skin of guinea pigs at the I. scapularis bite sites elucidated selected pathways, including histamine activation, that are associated with the development of erythema. The study demonstrates that an mRNA vaccine encoding a small peptide can induce the initial phase of ATR in guinea pigs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cui Y, Cibichakravarthy B, Tang X, et al. Salp14 epitope-based mRNA vaccination induces early recognition of a tick bite. Vaccine. 2024. PMID: 39236403. doi:10.1016/j.vaccine.2024.126304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。